LENTISEQ

Gammaretroviral and lentiviral vectors

Gammaretroviral and lentiviral vectors are powerful tools for cell and gene therapy. Comprehensive characterization of process- and product-related impurities in retroviral drug products contributes to the safety of in vivo and ex vivo therapies.

Comprehensive retroviral vector quality and safety assessment

GeneWerk combines powerful NGS-based retroviral genome sequencing and dedicated bioinformatics pipelines to identify and quantify residual DNA impurities and analyze retroviral genome identity and integrity. Furthermore, our customized bioinformatics analysis gives clients more control at every stage, from vector design to vector CMC procedure optimization, leading to improved vector batch control.

LENTISEQ provides a more comprehensive picture of vector quality and safety than standard qPCR-based impurity detection since it overcomes the need for a primer binding site. Apart from the origin and quantity of impurities, LENTISEQ provides information about vector identity and integrity.

A more cost-efficient
alternative to qPCR

Compared to qPCR, LENTISEQ is around 8-10 times cheaper for more than three loci and provides comprehensive information, including origin, quantity, special characterization of producer cell-derived impurities, vector identity, and vector integrity.

Want to get in touch?

Read our latest press releases and announcements below.

Contact us

Latest news

Read about what's been happening here at GeneWerk.

Protagen Protein Services merges with GeneWerk

Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand...

Read More

GeneWerk Announces Growth Equity Investment from Ampersand…

GeneWerk will expand capabilities to meet rapidly growing demand for cell and gene therapy...

Read More

Insight into Spatial and Temporal Trends of…

Genewerk GmbH in collaboration with University Heidelberg Germany provided an insight into spatial and...

Read More

GeneWerk in the Holiday Park

A little fun for everyone! This year’s company trip took us to the Holiday...

Read More
I agree to the Privacy Policy and Terms of Service.